Cost‐Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension

Primary aldosteronism (PA) is present in up to 20% of patients with treatment‐resistant hypertension (TRH). Investigation for PA in patients with TRH is recommended by current guidelines after medication nonadherence is excluded. Studies using therapeutic drug monitoring (TDM) have shown that >50...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Hypertens (Greenwich)
Prif Awduron: Velasco, Alejandro, Chung, Oliver, Raza, Fayez, Pandey, Ambarish, Brinker, Stephanie, Arbique, Debbie, Price, Angela, Lotan, Yair, Das, Sandeep R., Vongpatanasin, Wanpen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2015
Pynciau:
Original Papers
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4562815/
https://ncbi.nlm.nih.gov/pubmed/25917401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12570
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg